Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanouil Fokas

Showing results (31-40 of 158) with videos related to

Pageof 16
Sort By:
Expert Opinion on Drug Discovery|May 20, 2022
Advances in nanotechnology-based platforms for survivin-targeted drug discoveryRosemol George, Stephanie Hehlgans, Maximillian Fleischmann, et al.
BMC Cancer|August 5, 2010
Siah1 proteins enhance radiosensitivity of human breast cancer cellsHai-Tao He, Emmanouil Fokas, An You, et al.
Clinical Colorectal Cancer|August 24, 2011
Multidisciplinary treatment of brain metastases derived from colorectal cancer incorporating stereotactic radiosurgery: analysis of 78 patientsEmmanouil Fokas, Martin Henzel, Klaus Hamm, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 19, 2010
Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patientsEmmanouil Fokas, Martin Henzel, Klaus Hamm, et al.
Journal of Neuro-Oncology|April 25, 2012
Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastasesEmmanouil Fokas, Martin Henzel, Gunnar Surber, et al.
Thoracic Cancer|November 1, 2010
EphA2 blockade enhances the anti-endothelial effect of radiation and inhibits irradiated tumor cell-induced migration of endothelial cellsEmmanouil Fokas, Florentine Kamlah, Jörg Hänze, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 17, 2009
Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?Emmanouil Fokas, Ulrich Wacker, Markus W Gross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2023
Early Efficacy End Points in Neoadjuvant Rectal Cancer Trials: Surrogacy RevisitedEmmanouil Fokas, J Joshua Smith, Julio Garcia-Aguilar, et al.
JAMA Network Open|September 12, 2024
Persistent Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Rectal CancerMarkus Diefenhardt, Daniel Martin, Ralf-Dieter Hofheinz, et al.
Cancers|November 9, 2024
Tumor Response and Its Impact on Treatment Failure in Rectal Cancer: Does Intensity of Neoadjuvant Treatment Matter?Markus Diefenhardt, Daniel Martin, Maximilian Fleischmann, et al.
Pageof 16

Showing results (31-40 of 158) with videos related to

Sort By:
Pageof 16
Expert Opinion on Drug Discovery|May 20, 2022
Advances in nanotechnology-based platforms for survivin-targeted drug discoveryRosemol George, Stephanie Hehlgans, Maximillian Fleischmann, et al.
BMC Cancer|August 5, 2010
Siah1 proteins enhance radiosensitivity of human breast cancer cellsHai-Tao He, Emmanouil Fokas, An You, et al.
Clinical Colorectal Cancer|August 24, 2011
Multidisciplinary treatment of brain metastases derived from colorectal cancer incorporating stereotactic radiosurgery: analysis of 78 patientsEmmanouil Fokas, Martin Henzel, Klaus Hamm, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 19, 2010
Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patientsEmmanouil Fokas, Martin Henzel, Klaus Hamm, et al.
Journal of Neuro-Oncology|April 25, 2012
Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastasesEmmanouil Fokas, Martin Henzel, Gunnar Surber, et al.
Thoracic Cancer|November 1, 2010
EphA2 blockade enhances the anti-endothelial effect of radiation and inhibits irradiated tumor cell-induced migration of endothelial cellsEmmanouil Fokas, Florentine Kamlah, Jörg Hänze, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 17, 2009
Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?Emmanouil Fokas, Ulrich Wacker, Markus W Gross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2023
Early Efficacy End Points in Neoadjuvant Rectal Cancer Trials: Surrogacy RevisitedEmmanouil Fokas, J Joshua Smith, Julio Garcia-Aguilar, et al.
JAMA Network Open|September 12, 2024
Persistent Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Rectal CancerMarkus Diefenhardt, Daniel Martin, Ralf-Dieter Hofheinz, et al.
Cancers|November 9, 2024
Tumor Response and Its Impact on Treatment Failure in Rectal Cancer: Does Intensity of Neoadjuvant Treatment Matter?Markus Diefenhardt, Daniel Martin, Maximilian Fleischmann, et al.
Pageof 16